Oxford says vaccine has good immune response with two dose regime


London, December 17

Oxford’s COVID-19 vaccine candidate stimulates broad antibody and T cell responses and has the best immune response when a two full-dose regime is used, the university said, citing more detailed early stage trial data.

(Click here for the latest developments on Covid-19 epidemic)

The vaccine “stimulates broad antibody and T cell functions,” the university said after publishing further data from the Phase I/II clinical trials.

“The booster doses of the vaccine are both shown to induce stronger antibody responses than a single dose, the standard dose/standard dose inducing the best response.” Reuters



Be the first to comment on "Oxford says vaccine has good immune response with two dose regime"

Leave a comment

Your email address will not be published.


*


%d bloggers like this: